Cipla Promoters Sell 2.53% Stake
Cipla‘s Promoters Sell 2.53% Stake to Facilitate Philanthropic Endeavors Cipla’s main shareholders, including Shirin Hamied, Samina Hamied, Rumana Hamied, and Okasa Pharma, divested 20.45 million shares in block deals on Wednesday, generating approximately Rs 2,750 crore. Following the transaction, the entire promoter group maintains a 31.67% stake in Cipla, as per a company announcement to the stock exchange.
Notable buyers such as ICICI Prudential MF, Aditya Birla Sunlife MF, DSP MF, and the Saudi Central Bank acquired stakes. The deals, executed at Rs 1,345 per share, involved 60 buyers, including BOFA Securities, the Canadian Pacific Railway Company Pension Plan, the Government of Singapore, and the Monetary Authority of Singapore. Among the sellers, Rumana Hamied, Samina Hamied, Shirin Hamied, and Oksaka Pharma offloaded shares in varying proportions.
Before the transaction, the promoters collectively held a 4.26% stake, with Shirin Hamied, Samina Hamied, Rumana Hamied, and Okasa Pharma possessing distinct percentages. The promoter group’s majority stake of 33.47% included a significant portion held by MK Hamied, the non-executive vice chairman. Additionally, the company has committed to investing up to Rs 26 crore in Achira Labs, subject to specific milestones. On Wednesday, Cipla’s shares concluded trading at Rs 1,405.95 on the BSE, marking a 3.61% increase.
